June 23, 2021
Roche Diagnostics’ companion diagnostic (CDx) Ventana OptiView ALK (D5F3) has been approved in Japan for its additional use to identify patients suitable for Takeda Pharmaceutical’s ALK inhibitor Alunbrig (brigatinib), the two companies said on June 22. Up until now, the...read more